Hepatopulmonary syndrome
Hepatopulmonary syndrome (HPS) is a medical condition characterized by the triad of liver disease, arterial deoxygenation, and intrapulmonary vascular dilatations. It is a significant complication of cirrhosis and other forms of chronic liver disease.
Pathophysiology[edit | edit source]
Hepatopulmonary syndrome occurs due to the dilation of blood vessels in the lungs, which leads to abnormal oxygen exchange. The exact mechanism is not fully understood, but it is believed to involve increased production of nitric oxide and other vasodilators in the setting of liver disease. This results in the formation of microscopic intrapulmonary arteriovenous shunts, which impair oxygenation.
Clinical Features[edit | edit source]
Patients with hepatopulmonary syndrome typically present with symptoms of dyspnea (shortness of breath), platypnea (worsening of dyspnea when upright), and orthodeoxia (decrease in arterial oxygenation when upright). Other symptoms may include cyanosis, clubbing of the fingers, and signs of chronic liver disease such as jaundice, ascites, and spider angiomas.
Diagnosis[edit | edit source]
The diagnosis of hepatopulmonary syndrome is based on the presence of liver disease, arterial deoxygenation, and evidence of intrapulmonary vascular dilatations. Diagnostic tests include:
- Pulse oximetry and arterial blood gas analysis to assess oxygenation.
- Contrast-enhanced echocardiography to detect intrapulmonary shunting.
- Lung perfusion scan using technetium-99m-labeled macroaggregated albumin.
Treatment[edit | edit source]
There is no specific treatment for hepatopulmonary syndrome, and management primarily focuses on treating the underlying liver disease. Liver transplantation is the only definitive treatment and can lead to significant improvement or resolution of the syndrome. Supportive measures include oxygen therapy and management of complications related to liver disease.
Prognosis[edit | edit source]
The prognosis of hepatopulmonary syndrome varies depending on the severity of liver disease and the degree of hypoxemia. Patients with severe hypoxemia have a poorer prognosis. Liver transplantation can significantly improve outcomes in selected patients.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Hepatopulmonary syndrome Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD